Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects
Copyright ©2016 by The American Association of Immunologists, Inc. Diverse Ab effector functions mediated by the Fc domain have been commonly associated with reduced risk of infection in a growing number of nonhuman primate and human clinical studies. This study evaluated the anti-HIVAb effector act...
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | English |
| Published: |
The American Association of Immunologists
2021
|
| Online Access: | https://hdl.handle.net/1721.1/133926 |
| _version_ | 1826201098201858048 |
|---|---|
| author | Huang, Yunda Ferrari, Guido Alter, Galit Forthal, Donald N Kappes, John C Lewis, George K Love, J Christopher Borate, Bhavesh Harris, Linda Greene, Kelli Gao, Hongmei Phan, Tran B Landucci, Gary Goods, Brittany A Dowell, Karen G Cheng, Hao D Bailey-Kellogg, Chris Montefiori, David C Ackerman, Margaret E |
| author2 | Massachusetts Institute of Technology. Department of Chemical Engineering |
| author_facet | Massachusetts Institute of Technology. Department of Chemical Engineering Huang, Yunda Ferrari, Guido Alter, Galit Forthal, Donald N Kappes, John C Lewis, George K Love, J Christopher Borate, Bhavesh Harris, Linda Greene, Kelli Gao, Hongmei Phan, Tran B Landucci, Gary Goods, Brittany A Dowell, Karen G Cheng, Hao D Bailey-Kellogg, Chris Montefiori, David C Ackerman, Margaret E |
| author_sort | Huang, Yunda |
| collection | MIT |
| description | Copyright ©2016 by The American Association of Immunologists, Inc. Diverse Ab effector functions mediated by the Fc domain have been commonly associated with reduced risk of infection in a growing number of nonhuman primate and human clinical studies. This study evaluated the anti-HIVAb effector activities in polyclonal serum samples from HIV-infected donors, VAX004 vaccine recipients, and healthy HIV-negative subjects using a variety of primary and cell line-based assays, including Ab-dependent cellular cytotoxicity (ADCC), Ab-dependent cell-mediated viral inhibition, and Abdependent cellular phagocytosis. Additional assay characterization was performed with a panel of Fc-engineered variants of mAb b12. The goal of this study was to characterize different effector functions in the study samples and identify assays that might most comprehensively and dependably capture Fc-mediated Ab functions mediated by different effector cell types and against different viral targets. Deployment of such assays may facilitate assessment of functionally unique humoral responses and contribute to identification of correlates of protection with potential mechanistic significance in future HIV vaccine studies. Multivariate and correlative comparisons identified a set of Ab-dependent cell-mediated viral inhibition and phagocytosis assays that captured different Ab activities and were distinct from a group of ADCC assays that showed a more similar response profile across polyclonal serum samples. The activities of a panel of b12 monoclonal Fc variants further identified distinctions among the ADCC assays. These results reveal the natural diversity of Fc-mediated Ab effector responses among vaccine recipients in the VAX004 trial and in HIV-infected subjects, and they point to the potential importance of polyfunctional Ab responses. |
| first_indexed | 2024-09-23T11:46:34Z |
| format | Article |
| id | mit-1721.1/133926 |
| institution | Massachusetts Institute of Technology |
| language | English |
| last_indexed | 2024-09-23T11:46:34Z |
| publishDate | 2021 |
| publisher | The American Association of Immunologists |
| record_format | dspace |
| spelling | mit-1721.1/1339262023-09-25T20:58:46Z Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects Huang, Yunda Ferrari, Guido Alter, Galit Forthal, Donald N Kappes, John C Lewis, George K Love, J Christopher Borate, Bhavesh Harris, Linda Greene, Kelli Gao, Hongmei Phan, Tran B Landucci, Gary Goods, Brittany A Dowell, Karen G Cheng, Hao D Bailey-Kellogg, Chris Montefiori, David C Ackerman, Margaret E Massachusetts Institute of Technology. Department of Chemical Engineering Massachusetts Institute of Technology. Department of Biological Engineering Copyright ©2016 by The American Association of Immunologists, Inc. Diverse Ab effector functions mediated by the Fc domain have been commonly associated with reduced risk of infection in a growing number of nonhuman primate and human clinical studies. This study evaluated the anti-HIVAb effector activities in polyclonal serum samples from HIV-infected donors, VAX004 vaccine recipients, and healthy HIV-negative subjects using a variety of primary and cell line-based assays, including Ab-dependent cellular cytotoxicity (ADCC), Ab-dependent cell-mediated viral inhibition, and Abdependent cellular phagocytosis. Additional assay characterization was performed with a panel of Fc-engineered variants of mAb b12. The goal of this study was to characterize different effector functions in the study samples and identify assays that might most comprehensively and dependably capture Fc-mediated Ab functions mediated by different effector cell types and against different viral targets. Deployment of such assays may facilitate assessment of functionally unique humoral responses and contribute to identification of correlates of protection with potential mechanistic significance in future HIV vaccine studies. Multivariate and correlative comparisons identified a set of Ab-dependent cell-mediated viral inhibition and phagocytosis assays that captured different Ab activities and were distinct from a group of ADCC assays that showed a more similar response profile across polyclonal serum samples. The activities of a panel of b12 monoclonal Fc variants further identified distinctions among the ADCC assays. These results reveal the natural diversity of Fc-mediated Ab effector responses among vaccine recipients in the VAX004 trial and in HIV-infected subjects, and they point to the potential importance of polyfunctional Ab responses. 2021-10-27T19:57:14Z 2021-10-27T19:57:14Z 2016 2019-09-09T16:10:28Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/133926 Huang, Y., et al. "Diversity of Antiviral Igg Effector Activities Observed in Hiv-Infected and Vaccinated Subjects." J Immunol 197 12 (2016): 4603-12. en 10.4049/JIMMUNOL.1601197 Journal of immunology Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf The American Association of Immunologists PMC |
| spellingShingle | Huang, Yunda Ferrari, Guido Alter, Galit Forthal, Donald N Kappes, John C Lewis, George K Love, J Christopher Borate, Bhavesh Harris, Linda Greene, Kelli Gao, Hongmei Phan, Tran B Landucci, Gary Goods, Brittany A Dowell, Karen G Cheng, Hao D Bailey-Kellogg, Chris Montefiori, David C Ackerman, Margaret E Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects |
| title | Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects |
| title_full | Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects |
| title_fullStr | Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects |
| title_full_unstemmed | Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects |
| title_short | Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects |
| title_sort | diversity of antiviral igg effector activities observed in hiv infected and vaccinated subjects |
| url | https://hdl.handle.net/1721.1/133926 |
| work_keys_str_mv | AT huangyunda diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects AT ferrariguido diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects AT altergalit diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects AT forthaldonaldn diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects AT kappesjohnc diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects AT lewisgeorgek diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects AT lovejchristopher diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects AT boratebhavesh diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects AT harrislinda diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects AT greenekelli diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects AT gaohongmei diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects AT phantranb diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects AT landuccigary diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects AT goodsbrittanya diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects AT dowellkareng diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects AT chenghaod diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects AT baileykelloggchris diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects AT montefioridavidc diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects AT ackermanmargarete diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects |